MedPath

How effective is bisphosphonates treatment in the patients with giant cell tumor of bone

Phase 2
Completed
Conditions
Health Condition 1: null- GIANT CELL TUMOR OF BONE
Registration Number
CTRI/2019/04/018576
Lead Sponsor
Department of Orthopaedics All India Institute Of Medical Science New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

All Patients of both genders and more than 12 years of age with primary and recurrent non-malignant Giant Cell Tumors of bones of extremities

Patients with normal renal functions as measured by standard renal function test

Patients giving informed consent for the study

Exclusion Criteria

Exclusion Criteria:

1.Patients with malignant and metastatic Giant Cell Tumors of bone

2.Patients not ready to give the consent for study

3.Patients with GCT of the axial skeleton

4.Patients with altered renal functions

5.Patients suffering from thyroid and parathyroid disorders

6.Patients with known allergies to bisphosphonates

7.Children less than 12 years of age

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath